Infectious Disease Clinics of North America

Papers
(The median citation count of Infectious Disease Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Candidemia and Invasive Candidiasis94
Aspergillosis94
Multidrug-Resistant Bacteria in the Community76
Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations72
Resistance in Vancomycin-Resistant Enterococci61
Cryptococcosis54
Mucormycosis54
Histoplasmosis46
Resistance to Antifungal Drugs36
Necrotizing Soft Tissue Infections36
Recent Trends in the Epidemiology of Fungal Infections35
Nosocomial Fungal Infections35
Aminoglycoside Resistance35
Coccidioidomycosis33
Staphylococcal Skin and Soft Tissue Infections33
Health Care–Acquired Infections in Low- and Middle-Income Countries and the Role of Infection Prevention and Control28
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection27
Emerging Issues in Antifungal Resistance26
Epidemiology of Lyme Disease26
Blastomycosis25
Nurses and Antimicrobial Stewardship24
Decolonization of Staphylococcus aureus23
Disinfection and Sterilization in Health Care Facilities23
Hepatitis B Virus Reactivation Potentiated by Biologics22
COVID-19 and Pregnancy21
Overview21
Agents of Last Resort20
COVID-19 Pathogenesis and Clinical Manifestations20
Vancomycin-Resistant Enterococci19
Skin and Soft Tissue Infections in Patients with Diabetes Mellitus17
Antifungals in Clinical Use and the Pipeline17
Skin and Soft Tissue Infections in Persons Who Inject Drugs17
Emerging Fungal Infections17
Gram-Negative Skin and Soft Tissue Infections16
Multidrug-Resistant Gram-Negative Bacteria16
Tuberculosis in Children16
Human Babesiosis15
Prevention of Central-Line Associated Bloodstream Infections15
Bacteremia due to Methicillin-Resistant Staphylococcus aureus14
Fungal Infections Potentiated by Biologics14
Infective Endocarditis in Persons Who Use Drugs14
Soft Tissue, Bone, and Joint Infections in People Who Inject Drugs14
Applying the Infectious Diseases Literature to People who Inject Drugs13
Awakening13
Surgical Site Infections13
Collaborative Antimicrobial Stewardship13
Antifungal Susceptibility Testing and Identification13
Lyme Arthritis13
The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections12
COVID-19 Vaccines12
Cellulitis12
Infection Prevention during the Coronavirus Disease 2019 Pandemic12
Approach to the Patient with a Skin and Soft Tissue Infection11
Powassan Virus Encephalitis11
Herpesvirus Infections Potentiated by Biologics11
Ventilator-Associated Events11
JC Polyomavirus Infection Potentiated by Biologics10
Epidemiology and Clinical Presentation of COVID-19 in Older Adults10
Infections Related to Biologics10
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children10
Water Safety and Health Care10
Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition10
Infectious Complications of Tyrosine Kinase Inhibitors in Hematological Malignancies9
Drug-Resistant Tuberculosis9
The Evolving Role of the Clinical Microbiology Laboratory in Identifying Resistance in Gram-Negative Bacteria9
Hand Hygiene, an Update9
COVID-19 in Children9
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant9
Urinary Tract Infections9
Health Care Environmental Hygiene9
Human Granulocytic Anaplasmosis9
Collaborative Antimicrobial Stewardship9
Outpatient Antimicrobial Treatment for People Who Inject Drugs8
Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines8
Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs8
Strategies for Effective Infection Prevention Programs7
Infectious Complications of Bite Injuries7
Uses of Procalcitonin as a Biomarker in Critical Care Medicine7
Health Care–Acquired Viral Respiratory Diseases7
Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host7
Syphilis7
Management and Prevention of Staphylococcus aureus Infections in Children7
SARS-CoV-2 Virology7
Immunology of Fungal Infections7
Distinguishing Cellulitis from Its Noninfectious Mimics7
Recommendations for Improving Antimicrobial Stewardship in Long-Term Care Settings Through Collaboration6
Update in Epidemiology and Management of Mycoplasma genitalium Infections6
Collaborative Antimicrobial Stewardship in the Emergency Department6
Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults6
Lyme Disease in Children6
Infectious Complications of Immune Checkpoint Inhibitors6
Methicillin-Resistant Staphylococcus aureus: An Update on Prevention and Control in Acute Care Settings6
Updates on Infection Control in Alternative Health Care Settings6
Collaborative Antimicrobial Stewardship for Surgeons6
Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics5
Sexually Transmitted Human Papillomavirus5
Diagnostic Testing for Lyme Disease5
Occupational Health Update5
COVID-19 in the Critically Ill Patient5
Reimagining Construction and Renovation of Health Care Facilities During Emergence from a Pandemic5
Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock5
Diagnostic Stewardship in the Pediatric Intensive Care Unit5
Update on the Epidemiology, Screening, and Management of Chlamydia trachomatis Infection5
Prevention of Infection due to Clostridium (Clostridioides) difficile5
Prevention of Mycobacterium tuberculosis Transmission in Health Care Settings5
Cardiac Manifestations of Lyme Disease5
When to Think About Other Borreliae:5
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus5
Persistent Symptoms After Treatment of Lyme Disease5
Antimicrobial Stewardship and the Infection Control Practitioner4
Cytokine Release Syndrome and Sepsis4
Pandemic Preparedness4
Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System4
Early Lyme Disease (Erythema Migrans) and Its Mimics (Southern Tick-Associated Rash Illness and Tick-Associated Rash Illness)4
The Current State and Future Directions of Inpatient Pediatric Antimicrobial Stewardship4
The Ongoing Threat of Antimicrobial Resistance4
Implant-Associated Spinal Infections in Children4
Stewardship-Hospitalist Collaboration4
Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases4
Skin and Soft Tissue Infections in Non–Human Immunodeficiency Virus Immunocompromised Hosts4
Genital Herpes Infection4
Mycobacterial Infections Potentiated by Biologics4
Laboratory Diagnosis for SARS-CoV-2 Infection4
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons3
The Geography of Opioid Use Disorder3
Management of Common Postoperative Infections in the Surgical Intensive Care Unit3
Collaborative Antimicrobial Stewardship3
Contemporary Treatment of Resistant Gram-Negative Infections in Pediatric Patients3
Health Care-Associated Infections in Older Adults3
Sexual Transmission of Viral Hepatitis3
Management of Opioid Use Disorder and Infectious Disease in the Inpatient Setting3
Updates in the Epidemiology, Approaches to Vaccine Coverage and Current Outbreaks of Measles3
Immunization of Solid Organ Transplant Candidates and Recipients3
Addressing the Intersection of Infectious Disease Epidemics and Opioid and Substance Use Epidemics3
Nervous System Lyme Disease–Facts and Fallacies3
Collaborative Antimicrobial Stewardship in the Health Department3
Early Disseminated Lyme Disease3
Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation3
Update in Human Immunodeficiency Virus and Aging2
Regarding Collaboration in Antimicrobial Stewardship2
Antiviral Therapeutics in Pediatric Transplant Recipients2
Challenges in Managing Gonorrhea and New Advances in Prevention2
Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings2
Skin and Soft Tissue Infections2
Vaccine-Preventable Diseases in Older Adults2
Occupational Health Update2
Bugs and Drugs2
Trichomoniasis2
Update on Clostridioides difficile Infection in Older Adults2
Pharmacologic Treatment and Management of Coronavirus Disease 20192
Direct T-cell Inhibition and Agents Targeting T-cell Migration and Chemotaxis2
Antibiotic Stewardship1
The Intersection of Age and Infections: Understanding the Impacts from Diagnosis to Management1
Behavioral Strategies in Diagnostic Stewardship1
Minimizing the Risk of Donor-Derived Events and Maximizing Organ Utilization Through Education and Policy Development1
Mycobacteria in Organ Transplant Recipients1
Approach to Managing Sex Partners of People with Sexually Transmitted Infections1
ICU Management of Invasive β-Hemolytic Streptococcal Infections1
Computer Informatics for Infection Control1
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients1
Targets and Methods to Improve Outpatient Antibiotic Prescribing for Pediatric Patients1
Infections Related to Biologics1
Lessons Learned from the Response to the Human Immunodeficiency Virus Epidemic that Can Inform Addressing the Opioid Epidemic1
Sexually Transmitted Infections in Older Adults1
Next Steps in Ambulatory Stewardship1
Demographic and Geographic Inequities in Antimicrobial Use and Prescribing1
Outbreaks in Health Care Settings1
Infection Prevention and Control in Health Care, Part II: Management of Infections1
Lyme Disease and the Expanded Spectrum of Blacklegged Tick-Borne Infections1
Advances in Diagnostics of Sexually Transmitted Infections1
The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections1
Outpatient Parenteral Antibiotic Therapy in Older Adults1
Emerging Diagnostics and Therapeutics for Invasive Fungal Infections1
Management of Children with Reported Penicillin Allergies1
0.020550012588501